Assessing central sensitization with quantitative sensory testing in inflammatory rheumatic diseases: A systematic

Anne-Priscille Trouvin1, Nadine Attal2, Serge Perrot1

  • 1INSERM U987, Paris, France; Centre d'évaluation et traitement de la douleur, GHU Paris centre-Cochin, Paris, France; Université de Paris, Paris, France.

Joint Bone Spine
|May 3, 2022
PubMed
Summary

Pain in inflammatory rheumatic diseases is linked to reduced pressure pain thresholds (allodynia). However, evidence for central sensitization, a key chronic pain mechanism, remains inconclusive due to inconsistent quantitative sensory testing results.

Related Concept Videos